Stryker completes acquisition of ZuriMED

Stryker Corporation has finalized its acquisition of ZuriMED, a medical technology company originating from the Balgrist University Hospital. The deal focuses on the integration of the FiberLocker system, a technology designed to enhance the biomechanical strength of rotator cuff repairs during surgical tendon reconstructions.

The FiberLocker system was developed to address clinical challenges where traditional sutures can cut through soft tissue, potentially compromising reconstruction stability. By acquiring ZuriMED, Stryker aims to expand its sports medicine and shoulder implant portfolio with a commercially available technology rather than a developmental project.

While the acquisition strengthens Stryker's specialized expertise in shoulder care, the specific purchase price and financial terms were not disclosed. The company's broader financial outlook for 2026 includes projected organic revenue growth of 8.3% to 9.3% and adjusted earnings per share between $14.95 and $15.10.